Displaying drugs 6351 - 6375 of 8500 in total
Dexloxiglumide
Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist in phase III testing by Rottapharm in Europe only, as U.S. trials have been discontinued. As the D-isomer of loxiglumide, it retains all pharmacological properties of loxiglumide but is more potent.
Investigational
Matched Iupac: … (4R)-4-[(3,4-dichlorophenyl)formamido]-4-[(3-methoxypropyl)(pentyl)carbamoyl]butanoic acid …
2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE
Experimental
Matched Name: … 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2- …
Matched Iupac: … (2R,6S)-2-amino-6-[(4R)-4-carboxy-4-[(2S)-2-[(2R)-2-{[(1R,2S,3R,4R,5R)-4-acetamido-2-{[(2S,3R,4R,5S,6R ... )-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6,8-dioxabicyclo[3.2.1]octan-3-yl]oxy}propanamido …
Matched Iupac: … (2R,6S)-2-amino-6-[(4R)-4-carboxy-4-[(2S)-2-[(2R)-2-{[(1R,2S,3R,4R,5R)-4-acetamido-2-{[(2S,3R,4R,5S,6R ... )-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6,8-dioxabicyclo[3.2.1]octan-3-yl]oxy}propanamido …
N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE
Experimental
Matched Name: … N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE …
Matched Iupac: … N-[4-(2-chlorophenyl)-1,3-dioxo-1H,2H,3H,6H-pyrrolo[3,4-c]carbazol-9-yl]formamide …
Matched Iupac: … N-[4-(2-chlorophenyl)-1,3-dioxo-1H,2H,3H,6H-pyrrolo[3,4-c]carbazol-9-yl]formamide …
Hydrocortisone aceponate
Experimental
Vet approved
2,4-Dihydroxy-3,3-Dimethyl-Butyrate
Experimental
4-(Acetylamino)-3-Amino Benzoic Acid
Experimental
Matched Name: … 4-(Acetylamino)-3-Amino Benzoic Acid …
Matched Iupac: … 3-amino-4-acetamidobenzoic acid …
Matched Iupac: … 3-amino-4-acetamidobenzoic acid …
4-(2-aminoethyl)-2-cyclohexylphenol
Experimental
Matched Name: … 4-(2-aminoethyl)-2-cyclohexylphenol …
Matched Iupac: … 4-(2-aminoethyl)-2-cyclohexylphenol …
Matched Iupac: … 4-(2-aminoethyl)-2-cyclohexylphenol …
4-TERT-BUTYLBENZENESULFONIC ACID
Experimental
Matched Name: … 4-TERT-BUTYLBENZENESULFONIC ACID …
Matched Iupac: … 4-tert-butylbenzene-1-sulfonic acid …
Matched Iupac: … 4-tert-butylbenzene-1-sulfonic acid …
(3S)-Tetrahydro-3-furanyl {(2S,3S)-4-[(2S,4R)-4-{(1S,2R)-2-[(S)-amino(hydroxy)methoxy]-2,3-dihydro-1H-inden-1-yl}-2-benzyl-3-oxo-2-pyrrolidinyl]-3-hydroxy-1-phenyl-2-butanyl}carbamate
Experimental
Matched Name: … (3S)-Tetrahydro-3-furanyl {(2S,3S)-4-[(2S,4R)-4-{(1S,2R)-2-[(S)-amino(hydroxy)methoxy]-2,3-dihydro-1H-inden …
Matched Iupac: … (3S)-oxolan-3-yl N-{4-[(2S,4R)-4-[(1S,2R)-2-[(S)-amino(hydroxy)methoxy]-2,3-dihydro-1H-inden-1-yl]-2- …
Matched Iupac: … (3S)-oxolan-3-yl N-{4-[(2S,4R)-4-[(1S,2R)-2-[(S)-amino(hydroxy)methoxy]-2,3-dihydro-1H-inden-1-yl]-2- …
Icotinib
Icotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)
Icotinib was approved in China by the SFDA in June, 2011 and in January 2014, Beta Pharma, Inc. was given a “May Proceed” from the US FDA to conduct a Phase I study for the...
Experimental
Investigational
Matched Iupac: … N-(3-ethynylphenyl)-7H,8H,10H,11H,13H,14H-1,4,7,10-tetraoxacyclododeca[2,3-g]quinazolin-4-amine …
Nabiximols
Nabiximols (tradename Sativex®) is a whole plant extract from the Cannabis species Cannabis sativa L. that has been purified into the active components CBD (cannabidiol) and THC (delta-9-tetrahydrocannabinol). For trademark purposes, purified CBD is branded as Nabidiolex®, while THC is purified as the product Tetrabinex®. Sativex® is available in a...
Investigational
Matched Iupac: … 6H,6aH,7H,8H,10aH-benzo[c]isochromen-1-ol; 2-[(1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]-5- …
L-Threonohydroxamate 4-Phosphate
Experimental
Matched Name: … L-Threonohydroxamate 4-Phosphate …
Matched Iupac: … [(2S,3R,4S)-2,3,4-trihydroxy-4-(hydroxyamino)butoxy]phosphonic acid …
Matched Iupac: … [(2S,3R,4S)-2,3,4-trihydroxy-4-(hydroxyamino)butoxy]phosphonic acid …
2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID
Experimental
Matched Name: … 2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID …
Matched Iupac: … 2-[(1E)-2-(4-hydroxyphenyl)diazen-1-yl]benzoic acid …
Matched Iupac: … 2-[(1E)-2-(4-hydroxyphenyl)diazen-1-yl]benzoic acid …
2-Amino-4-(2-Amino-Ethoxy)-Butyric Acid
Experimental
Matched Name: … 2-Amino-4-(2-Amino-Ethoxy)-Butyric Acid …
Matched Iupac: … (2S)-2-amino-4-(2-aminoethoxy)butanoic acid …
Matched Iupac: … (2S)-2-amino-4-(2-aminoethoxy)butanoic acid …
1-[4-(hydroxymethyl)phenyl]guanidine
Experimental
Matched Name: … 1-[4-(hydroxymethyl)phenyl]guanidine …
Matched Iupac: … N-[4-(hydroxymethyl)phenyl]guanidine …
Matched Iupac: … N-[4-(hydroxymethyl)phenyl]guanidine …
1-(4-thiophen-2-ylphenyl)methanamine
Experimental
Matched Name: … 1-(4-thiophen-2-ylphenyl)methanamine …
Matched Iupac: … 1-[4-(thiophen-2-yl)phenyl]methanamine …
Matched Iupac: … 1-[4-(thiophen-2-yl)phenyl]methanamine …
VLX-1005
Investigational
Matched Synonyms: … N-Benzothiazol-2-yl-4-(2-hydroxy-3-methoxy-benzylamino)-bezenesulfonamide ... Benzenesulfonamide, n-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)- ... N-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)benzenesulfonamide …
Matched Iupac: … N-(1,3-benzothiazol-2-yl)-4-{[(2-hydroxy-3-methoxyphenyl)methyl]amino}benzene-1-sulfonamide …
Matched Iupac: … N-(1,3-benzothiazol-2-yl)-4-{[(2-hydroxy-3-methoxyphenyl)methyl]amino}benzene-1-sulfonamide …
Denecimig
Delpacibart is a humanized, bispecific, bivalent monoclonal antibody against coagulation factor 9.
Investigational
Burfiralimab
Burfiralimab is under investigation in clinical trial NCT06306339 (A Study to Assess the Efficacy and Safety of Burfiralimab (Hzvsf-v13) and DMRD (Disease-modifying Antirheumatic Drug)).
Investigational
Matched Synonyms: … IMMUNOGLOBULIN G4, ANTI-(HUMAN VIMENTIN) (HUMAN-MUS MUSCULUS .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS …
QN-302
Investigational
Matched Synonyms: … 2,7-bis(3-morpholinopropyl)-4-((2-(pyrrolidin-1-yl)ethyl)amino)-9-(4-(pyrrolidin-1-ylmethyl)phenyl)benzo …
Matched Iupac: … 6,13-bis[3-(morpholin-4-yl)propyl]-2-{[2-(pyrrolidin-1-yl)ethyl]amino}-9-{4-[(pyrrolidin-1-yl)methyl] …
Matched Iupac: … 6,13-bis[3-(morpholin-4-yl)propyl]-2-{[2-(pyrrolidin-1-yl)ethyl]amino}-9-{4-[(pyrrolidin-1-yl)methyl] …
BC9KBY85WY
Investigational
Matched Synonyms: … 1-piperazinecarboxamide, 4-((2e)-1-oxo-3-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-propen-1-yl)- ... 4-((2E)-1-Oxo-3-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-propen-1-yl)-1-piperazinecarboxamide …
Matched Iupac: … 4-[(2E)-3-(2,6,6-trimethylcyclohex-1-en-1-yl)prop-2-enoyl]piperazine-1-carboxamide …
Matched Iupac: … 4-[(2E)-3-(2,6,6-trimethylcyclohex-1-en-1-yl)prop-2-enoyl]piperazine-1-carboxamide …
Ginisortamab
Ginisortamab is under investigation in clinical trial NCT04393298 (A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors).
Investigational
Matched Synonyms: … Immunoglobulin g4 (232-proline), anti-(human gremlin 1) (human monoclonal ucb6114 .gamma.4-chain), disulfide …
Carotuximab
Investigational
Homocysteine
Homocysteine is a thiol-containing amino acid formed by a demethylation of methionine.
Experimental
Matched Synonyms: … L-2-amino-4-mercaptobutyric acid …
Matched Iupac: … (2S)-2-amino-4-sulfanylbutanoic acid …
Matched Iupac: … (2S)-2-amino-4-sulfanylbutanoic acid …
PD-168393
PD-168393 is an epidermal growth factor receptor inhibitor.
Experimental
Matched Synonyms: … 4-[(3-bromophenyl)amino]-6-acrylamidoquinazoline …
Matched Iupac: … N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}prop-2-enamide …
Matched Iupac: … N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}prop-2-enamide …
Displaying drugs 6351 - 6375 of 8500 in total